Trusts should aim to recruit at least 60% of eligible COVID-19 patients into trials
News
Single radiotherapy shot proves effective in breast cancer
The treatment, developed by UCL clinicians, allows for surgery and radiation therapy at the same time
Roche and Regeneron link over antiviral antibody combo
The agreement is expected to boost supply of REGN-COV2 to at least three and a half times current capacity
First trial participant gets GSK’s 5-in-1 meningitis jab
The Phase III study is evaluating the safety, tolerability and immunogenicity of GSK’s MenABCWY vaccine candidate compared to Bexsero and Menveo
Skin cancer deaths rocket 70% since the 1970s
Melanoma incidence rates have more than doubled in the UK
Survey reveals Britains welcome shift to virtual healthcare
Findings also show increased trust in pharma and healthcare
Verona progresses PhII trial of COPD inhaler
Following a pause because of coronavirus, the company has now kicked off the second part of a trial assessing a pressurised metered-dose inhaler formulation of ensifentrine
Priority review for Imfinzi’s less-frequent dosing regimen
AZ says approval would “simplify and improve treatment by enabling continuity of care while minimising the risk of exposure to infection in the healthcare setting”
Gov announces expansion of UK’s ONS COVID-19 survey
Plans have been announced to test 150,000 people per fortnight across the UK from October
Hancock confirms replacement of Public Health England
The National Institute for Health Protection (NIHP) will bring together the pandemic response work of PHE and NHS Test and Trace
Roche’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder
Enspryng is the first approved therapy for NMOSD designed to target and inhibit interleukin-6 receptor activity, using novel recycling antibody technology
EU regulators to review Evrysdi for SMA
The decision triggers a £15m milestone payment from Roche to PTC Therapeutics
Study confirms link between SABA inhalers and asthma exacerbations
High SABA inhaler use was associated with around twice the number of exacerbations, the SABINA study found
Doctors express concern over clearing NHS bottleneck
The survey, by the British Medical Association, highlights the huge challenge in returning to a normal service as waiting lists grow
Sanofi buys Principia Biopharma
The move bolsters the French drug giant’s core R&D areas of autoimmune and allergic diseases
